Does the presence of cardiac amyloidosis worsen prognosis in patients with severe aortic stenosis undergoing TAVR?
Concomitant cardiac amyloidosis can be identified via ECG and echocardiography and does not significantly worsen mid-term prognosis after TAVR in patients with severe aortic stenosis.
Both TTR- and AL-CA can accompany severe AS. Parameters solely based on ECG and echocardiography allow for the identification of the majority of CA-AS. In the present cohort, CA did not significantly worsen prognosis 15.3 months after TAVR.
Nitsche et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: